Department of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St., 100 Centrex, Philadelphia, PA, 19104, USA.
J Gen Intern Med. 2012 Nov;27(11):1544-7. doi: 10.1007/s11606-012-2050-4. Epub 2012 Apr 5.
United States health expenditures continue to escalate at unsustainable rates. A recent movement around increasing price transparency has been suggested as a way of reducing the rate of increase in expenditures, with legislative efforts taking place at both the state and federal level. While this seems on the surface like a good idea, simply providing information on prices to physicians, particularly trainees, may not achieve the type of large changes in practice patterns that proponents expect. The manner in which price transparency is implemented will likely play a significant role in its effectiveness as an intervention. In this article, the authors review efforts of transparency and default options from other contexts and leverage insights from behavioral economics to provide recommendations for increasing the likelihood that price transparency will lead to physicians weighing the relative value of interventions.
美国卫生支出继续以不可持续的速度攀升。最近有人提议提高价格透明度，以此来降低支出增长率，州政府和联邦政府都在为此做出努力。虽然这从表面上看是个好主意，但仅仅向医生，尤其是培训医师提供价格信息，可能无法实现相关人士所期望的那种大幅改变医疗实践模式的效果。价格透明度的实施方式可能会对其干预效果产生重大影响。在本文中，作者回顾了其他背景下的透明度和默认选项的相关努力，并借鉴行为经济学的相关见解，为提高价格透明度更有可能促使医生权衡干预措施的相对价值提供了相关建议。
